High materiality8/10
Quince Therapeutics initiated with an Outperform at Raymond James
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Raymond James initiates QNCX with Outperform; target $72; current price $29.36. Strong upside implied by initiation.
- Outperform target $72 vs price $29.36
- Raymond James initiation
Key facts
- 01
Target: $72
- 02
Posted price: $29.36
- 03
Analyst firm: Raymond James
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.